Services

Technical & Educational Articles

With the increased prevalence of diseases that have defied cures for ages such as cancer and neurodegenerative diseases as well as the resurgence of drug-resistant microbial or viral pathogens, there is an urgent need to develop innovative and efficacious therapies. One such modality is genetic therapy, which has acquired momentum following the identification of multiple genes, whose disruption predisposes to various human disorders. Though the exact mechanisms through which these alterations cause the disorders are still being deciphered, pharmaceutical industries have increasingly been focusing on molecular interactions or signaling initiated by the gene products for target-based drug discovery. This is also the case for virally induced immune disorders like AIDS, whose infectious agent HIV has been extensively characterized at the molecular 
level. Previously, to abrogate the propagation of cancer cells, modified nucleosides have been administered to interfere with DNA replication. Likewise, for HIV, nucleoside analogs have been used to inhibit reverse transcriptase essential for its replication. Nevertheless, the present inability to treat recurrent cancers or eliminate the viruses calls for the need to develop alternative strategies.Against this backdrop, the potential use of oligonucleotides as therapeutics is increasingly being explored.

For further information you may download our handbook  Oligonucleotide Therapeutics Handbook.pdf    

 


 

Why Choose Bio-Synthesis

Trusted by biotech leaders worldwide for over 45 years of delivering high-quality, fast, and scalable synthetic biology solutions.